Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Key benefits for perimenopausal women: Targets visceral and subcutaneous fat accumulation that tends to increase as estrogen declines and metabolism slows Does not affect blood sugar or cause stimulant-related side effects such as anxiety or elevated heart rate Supports fat loss while preserving lean muscle tissue, important for maintaining metabolic rate during hormonal transition Administration method: Subcutaneous injection into abdominal fatty tissue, typically 2 inches from the navel
However, any resulting weight loss is gradual and depends entirely on your ability to maintain a consistent calorie deficit over weeks and months
For patients with existing heart disease, semaglutide's proven CV benefit is a major differentiator
The 7.2 mg semaglutide group had a greater mean weight loss than the 2.4 mg group, at -18.7% vs -15.6%, respectively
Women exploring these options should also understand the broader context of peptide applications and how weight management fits into the larger picture of menopausal health optimization
If you are currently taking semaglutide (Wegovy, Ozempic or Rybelsus) and notice sudden loss of vision or other vision changes, you should seek urgent medical assistance and urgently attend eye casualty or A&E
